Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoquinone as an Adjuvant Treatment With Pregabalin for Diabetic Neuropathy
NCT07313111Phase 4Completed
- Sponsor
- Hawler Medical University
- Start
- Jul 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of thymoquinone in diabetic peripheral neuropathy (DPN), sponsored by Hawler Medical University. Started Jul 2024; status: completed.
02
Drugs
thymoquinone
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07313111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07313111.